| 16/09/24 | 14:31:43 | 16 Sept 2024 | | PDS: Updated Results, VERSATILE-002 Phase 2 Trial |
| 13/08/24 | 15:57:46 | 13 Aug 2024 | | PDS Biotech: Business Update and Q2 2024 Results |
| 02/08/24 | 12:21:26 | 2 Aug 2024 | | Replacement RNS: PDS Biotech Aligns with FDA |
| 02/08/24 | 07:00:05 | 2 Aug 2024 | | PDS Biotech Aligns with FDA on Phase 3 Trial |
| 30/07/24 | 07:00:10 | 30 Jul 2024 | | Q-Bot Fundraising |
| 10/07/24 | 10:48:07 | 10 Jul 2024 | | Result of AGM |
| 18/06/24 | 07:00:10 | 18 Jun 2024 | | Notice of AGM |
| 14/06/24 | 14:10:05 | 14 Jun 2024 | | TR-1 |
| 14/06/24 | 07:00:11 | 14 Jun 2024 | | Director/PDMR Shareholding |
| 13/06/24 | 07:00:10 | 13 Jun 2024 | | Preliminary Results for the year ended 31 Dec 2023 |
| 31/05/24 | 07:01:01 | 31 May 2024 | | Notice of Results and Investor Presentation |
| 31/05/24 | 07:00:08 | 31 May 2024 | | DeepTech Recycling: Fundraising, Business Update |
| 28/05/24 | 07:00:16 | 28 May 2024 | | Investment in Wanda, related party transactions |
| 15/05/24 | 14:32:19 | 15 May 2024 | | PDS Biotech: Business Update and Q1 2024 Results |
| 13/05/24 | 07:00:08 | 13 May 2024 | | Martlet Capital: mandate and acquisition |
| 10/05/24 | 09:12:39 | 10 May 2024 | | PDS Biotech: Clinical trial meets study endpoints |
| 15/04/24 | 07:00:08 | 15 Apr 2024 | | ProAxsis secures c.£1.8mn investment |
| 27/03/24 | 13:34:25 | 27 Mar 2024 | | PDS Strategy Update and 2023 Financial Results |
| 13/03/24 | 07:00:08 | 13 Mar 2024 | | Business Update |
| 05/02/24 | 07:00:09 | 5 Feb 2024 | | Exercise of Options and Issue of Shares |
| 23/01/24 | 07:00:10 | 23 Jan 2024 | | Glycotest secures $1 million investment |
| 01/12/23 | 07:00:09 | 1 Dec 2023 | | DeepTech Recycling secures £1 million investment |
| 14/11/23 | 16:39:35 | 14 Nov 2023 | | PDS BioTechnology: Third Quarter Results |
| 13/11/23 | 07:00:13 | 13 Nov 2023 | | Director/PDMR Shareholding |
| 09/11/23 | 17:28:57 | 9 Nov 2023 | | PDS Biotech Announces Updated Survival Data |
| 06/11/23 | 07:00:13 | 6 Nov 2023 | | Ventive secures c.£900,000 investment |
| 02/11/23 | 07:00:12 | 2 Nov 2023 | | Change of Adviser |
| 23/10/23 | 18:22:50 | 23 Oct 2023 | | PDS Preliminary Biomarker Study Results |
| 13/10/23 | 07:00:10 | 13 Oct 2023 | | Exercise of Options |
| 03/10/23 | 16:12:06 | 3 Oct 2023 | | Director/PDMR Shareholding |
| 03/10/23 | 15:21:51 | 3 Oct 2023 | | PDS: Interim 24-month survival rate of 74% update |
| 03/10/23 | 07:00:09 | 3 Oct 2023 | | PDS Biotech: new data on PDS0101 |
| 28/09/23 | 07:00:08 | 28 Sept 2023 | | Interim Results |
| 13/09/23 | 07:00:07 | 13 Sept 2023 | | Q-Bot: £3.5 million investment to drive expansion |
| 14/08/23 | 17:55:13 | 14 Aug 2023 | | PDS Biotech: 2nd Quarter Results, Business Update |
| 14/08/23 | 17:51:33 | 14 Aug 2023 | | PDS Biotech: Submission of Phase 3 Protocol to FDA |
| 03/07/23 | 07:00:06 | 3 Jul 2023 | | Grant of Options, Issue of Shares, Director/PDMR |
| 30/06/23 | 07:00:11 | 30 Jun 2023 | | DName-iT Holdings Limited Fundraising |
| 29/06/23 | 11:04:49 | 29 Jun 2023 | | Result of AGM & Board Changes |
| 22/06/23 | 07:00:06 | 22 Jun 2023 | | Vortex Fundraising |
| 14/06/23 | 15:31:03 | 14 Jun 2023 | | PDS Announces Achievement of Efficacy Threshold |
| 07/06/23 | 07:00:05 | 7 Jun 2023 | | Director/PDMR Shareholding |
| 06/06/23 | 07:00:08 | 6 Jun 2023 | | Notice of AGM |
| 31/05/23 | 07:01:02 | 31 May 2023 | | Preliminary Results for the year ended 31 Dec 2022 |
| 31/05/23 | 07:00:07 | 31 May 2023 | | Board Changes |
| 26/05/23 | 09:39:32 | 26 May 2023 | | PDS Biotech Announces Interim Data |
| 24/05/23 | 07:00:14 | 24 May 2023 | | Sofant and Inmarsat announce joint development |
| 15/05/23 | 15:16:19 | 15 May 2023 | | PDS Business Update and First Quarter Results |
| 02/05/23 | 07:00:09 | 2 May 2023 | | Glycotest, Inc. Fundraising |
| 03/04/23 | 07:00:15 | 3 Apr 2023 | | Business Update |
